US EditionPublished • loading... • Updated
The TEMPO Shift: What the FDA’s New Pilot Means for Interactive Medical Technology - Filament Games
The intersection of digital innovation and clinical validation has long been a bottleneck for medtech entrepreneurs. Traditionally, the path to market involved a rigorous clearance-first hierarchy that made it challenging for digital therapeutics to generate the real-world data they needed to prove long-term efficacy. However, the FDA’s recently launched Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot represents a targeted shift in …
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
The TEMPO Shift: What the FDA’s New Pilot Means for Interactive Medical Technology - Filament Games
The intersection of digital innovation and clinical validation has long been a bottleneck for medtech entrepreneurs. Traditionally, the path to market involved a rigorous clearance-first hierarchy that made it challenging for digital therapeutics to generate the real-world data they needed to prove long-term efficacy. However, the FDA’s recently launched Technology-Enabled Meaningful Patient Outcomes (TEMPO) pilot represents a targeted shift in …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
